CHICAGO, May 01, 2018 -- Lumere, a leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unwarranted clinical variation, today announced plans to collaborate with the Association of Healthcare Value Analysis Professionals’ (AHVAP) Industry Business Education Collaborative agreement.
This agreement includes educational offerings highlighting best-practice strategies and tactics to help health systems and value analysis professionals consistently apply evidence to clinical decisions. “Hospitals and clinicians are strapped to find the time and the resources to collect the vast amounts of available drug and device information and also to dissect and separate unbiased sources from biased ones,” said Lumere Chief Development Officer Gina Thomas, RN, MBA. “AHVAP is the perfect collaborator because of its dedication to applying a clinical and evidence-based perspective to the clinical decision process.”
According to AHVAP President Susan Knapp, RN, MS, CVAHP, the two organizations share a vision to improve patient value by reducing unnecessary clinical variation and reducing costs. “Variation in care is a major contributor to wasteful healthcare spending,” she said. “Our members have the potential to play important roles in curtailing that waste, and solutions like Lumere’s offer important resources for them and their facilities.”
According to Knapp, redefining and repositioning the role of value analysis offers an exceptional opportunity to bring about real change.
“Historically, value analysis leaders have had to react quickly to market place pressures. While that doesn’t change, integrating a clinical and evidence-based approach metric into all decisions will help advance the value analysis practice,” Knapp said.
Thomas, agrees with that assessment. “Our educational offerings will emphasize the fact that value analysis must be embedded within an organization’s clinical care governance as a patient-centered, multidisciplinary approach,” she said.
About Lumere
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.
About AHVAP
The Association of Healthcare Value Analysis Professionals (AHVAP) is an organization of professionals whose expertise bridges the gap between clinical and supply chain process. Through the use of evidence, clinical and financial expertise value analysis facilitators play a pivotal role to ensure effective decision-making that positively impacts clinical, operational and financial outcomes. For more information, visit AHVAP.org, find us on LinkedIn, follow @AHVAP on Twitter and like us on Facebook.
Media Contact
Pam Flores
[email protected]
(773) 218-9260


U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move
Middle East Conflict Impacts Australia and New Zealand Businesses
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds 



